Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from CVS

US reeling from tampon shortage as prices of menstrual products go up

CVS and Walgreens confirm some tampons out of stock as non-profits also seeing diminishing supplies

The Guardian - US

It's not just you: Tampons are harder to find — and pricier

Many women say store shelves that once had the menstrual essentials have been sparse for months. When they are available, tampons have been a lot more expensive recently, due in part to inflation.

WEKU

$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.19% on an annualized basis producing an average annual return of 8.99%. Currently, CVS Health has a market capitalization of $122.80 billion.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

This Is What Whales Are Betting On CVS Health

A whale with a lot of money to spend has taken a noticeably bearish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 11 strange trades.

Benzinga

Little Village community members demand CVS Pharmacy stay open

The Little Village store is one of 900 pharmacies being closed nationwide over the next three years.

Chicago Sun-Times

CVS Stops Filling Controlled Substance Prescriptions From Two Telehealth Firms: Report

CVS Health Corp. (NYSE: CVS) has stopped filling prescriptions for controlled substances requested by clinicians from the telehealth startup companies Cerebral Inc. and Done Health.

Benzinga

CVS Health To Stop Filling Controlled Substances Prescriptions For Cerebral, Done Health

CVS Health Corp (NYSE: CVS) will stop

Benzinga

Read news from The Economist, FT, and more,
with one subscription

If You Invested $1000 In CVS Health 20 Years Ago, Here's How Much You Would Have Today

CVS Health (NYSE:CVS) has outperformed the market over the past 20 years by 2.69% on an annualized basis producing an average annual return of 9.39%. Currently, CVS Health has a market capitalization of $126.32 billion.

Benzinga

3 Defensive Stocks to Consider Buying During the Market Downturn

The Fed’s aggressive interest rate increases to fight high inflation has raised concerns about a potential recession. During times of market turmoil, companies in defensive sectors will likely perform better than the broader market owing to inelastic demand for their products. Thus, we think it could be profitable now to…

StockNews.com

US baby formula crisis: What you need to know

Why is there an infant formula shortage in the US? Who is to blame? And when will parents see relief?

Al Jazeera

CVS Health Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on CVS Health. Looking at options history for CVS Health (NYSE:CVS) we detected 21 strange trades.

Benzinga

With Roe in doubt, some fear tech surveillance of pregnancy

Companies that collect data from the digital clues people leave online often know their most sensitive health information _ gleaned from web searches, health apps and location trackers

The Independent UK

With Roe in doubt, some fear tech surveillance of pregnancy

Companies that collect data from the digital clues people leave online often know their most sensitive health information _ gleaned from web searches, health apps and location trackers

The Independent UK

Gov won't say if Paxlovid is accessible

Officials won't say how many people have received antiviral pills, or if they're being equitably distributed

Salon

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Ohio Lawyer Says Pharmacy Distributors To Pay $878M For Opioid Epidemic

A lawyer for two Ohio counties said that CVS Health Corp (NYSE:CVS), Walgreens Boots Alliance Inc (NASDAQ:WBA), and Walmart Inc (NYSE:WMT) should fund an $878 million plan addressing the opioid crisis, writes Reuters. In November, a federal jury decided that the companies created a public nuisance by flooding Ohio's Lake and Trumbull counties with addictive prescription pain…

The Independent UK

Baby formula shortage forces parents to pay $120 for single can as Target, CVS and Walgreens limit sales

CVS and Walgreens are limiting customers to three toddler and infant formulas per purchase as the shortage worsens across the US

The Guardian - US

Ohio judge hears if pharmacy chains should pay for driving opioid crisis

CVS, Walgreens and Walmart Were found to recklessly dispense narcotic painkillers in two Ohio counties, fueling a drug epidemic

Benzinga

Amid Baby Formula Shortage, Retailers Put Cap On Purchases: Report

The U.S. faced a nationwide shortage of the most popular baby formula brands in the week starting April 24, according to the latest figures from Datasembly, which tracks out-of-stock messages on retailers' websites and apps. An average rate is less than 10%. Reasons For The Shortage: Supply chain issues caused by the COVID-19…

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Judge to decide abatement amounts in opioid pharmacy case

A hearing will begin Tuesday in federal court in Cleveland that will result in a judge determining how much CVSHealth, Walgreens Co. and Walmart Corp. should pay two northeast Ohio counties to help them abate the continuing opioid crisis

The Independent UK

Baby formula shortage forces parents to pay $120 for single can as Target, CVS and Walgreens limit sales

CVS and Walgreens are limiting customers to three toddler and infant formulas per purchase as the shortage worsens across the US

The Independent UK

Walgreens reaches $683m settlement with Florida over role in opioid crisis

The company settled over claims that it exacerbated the opioid crisis in the Sunshine State.

Benzinga

Where CVS Health Stands With Analysts

CVS Health (NYSE:CVS) has observed the following analyst ratings within the last quarter:

Benzinga

CVS Health's Return On Capital Employed Overview

According to Benzinga Pro, during Q1, CVS Health (NYSE:CVS) earned $2.31 billion, a 78.47% increase from the preceding quarter. CVS Health also posted a total of $76.83 billion in sales, a 0.29% increase since Q4.

Chicago Tribune

Want free, at-home COVID-19 tests from pharmacies and insurers? It’s not always easy, despite requirements

CHICAGO -- Some Illinois residents say they’re still having trouble getting free at-home COVID-19 tests from pharmacies and insurance companies, more than three months after the White House began requiring insurers to cover them.

Benzinga

Check Out What Whales Are Doing With CVS

Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

1 … 20 21 22 23

People

Joe Biden

67,518 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.